Angiotech's licensee enrolls first patient in renal artery disease trial - Trading Markets (press release) Print
Trading Markets (press release)The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of

... read more